[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Madrigal Pharmaceuticals, Inc. Common Stock
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$MDGL TRUIST INITIATES MADRIGAL PHARMACEUTICALS AT BUY WITH $XXX PRICE TARGET AND SAYS KOL FEEDBACK SHOWS HIGH INTEREST IN REZDIFFRA AND SUPPORTS PEAK SALES OF $6.2B"
X Link @WallStSai 2025-10-14T20:26Z 7560 followers, 1906 engagements
"Truist🏁 $MDGL Buy/$580 and says KOL Feedback Shows High Interest in Rezdiffra and Supports Peak Sales of $6.2B in its View. $IVA $NVO Truist said in its MDGL initiation: Key investment points - 1) First drug approved (Rezdiffra) for MASH with early launch metrics indicating high demand & potential for upside from continued strong launch; 2) Sizable opportunity in MASH (10-20M US patients) not fully reflected at current levels; 3) KOL feedback shows high interest in Rezdiffra in our view supports peak sales of $6.2B vs. $4.5B cons (2036E) in the approved F2/F3 subtype; 4) Potential for upside"
X Link @Quantumup1 2025-10-14T20:14Z 3827 followers, 5563 engagements
"$PGY $DLTR $MDGL To Analyst price target for next week-"
X Link @StockMarke18287 2025-10-14T19:09Z XXX followers, XXX engagements
"$RCM $DLTR $MDGL To Analyst price target for next week-"
X Link @StockMarke18287 2025-10-14T19:07Z XXX followers, XXX engagements